Plasma Therapy Market Outlook
Market Size and Growth
The global plasma therapy market is valued at US$36.04 billion in 2022, projected to grow at a CAGR of 9.14% from 2023 to 2030, reaching US$75.64 billion by the end of the forecast period.
Market Drivers
The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive treatments, and advancements in plasma processing technology.
Plasma therapy involves administering blood plasma from donors who have recovered from specific infections or diseases to patients suffering from the same conditions. It has shown promising results in treating autoimmune disorders, immune deficiencies, and infections.
Regional Landscape
North America held the largest market share in 2022, owing to the presence of well-established healthcare infrastructure and a high prevalence of chronic diseases. Asia-Pacific is expected to witness the fastest growth over the forecast period due to increasing healthcare awareness and government initiatives to improve healthcare access.
Conclusion
The plasma therapy market is poised for continued growth in the coming years. The increasing prevalence of chronic diseases, technological advancements, and the expanding healthcare infrastructure will drive market demand. As plasma therapy becomes more widely accepted and accessible, it is expected to play a significant role in improving patient outcomes and reducing the burden of chronic diseases globally.
Comments